Pediatrix Medical Group Inc.
MD | NYSE
$25.77
-$0.16 (-0.62%)
At close: Sep 21, 2026, 4:00 PM ET
$25.77
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.91B | 2.01B | 1.99B | 1.97B | 1.91B | 1.73B |
Cost of Revenue | 1.44B | 1.56B | 1.57B | 1.5B | 1.4B | 1.28B |
Gross Profit | 471.88M | 454.34M | 421.57M | 467.03M | 513.24M | 449.32M |
Operating Income | 231.09M | -68.71M | 7.32M | 172.69M | 202.92M | 98.13M |
Interest Income | 19.05M | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 216.43M | -101.34M | -48.36M | 81.37M | 135.23M | 7.15M |
Net Income | 165.39M | -99.07M | -60.41M | 66.34M | 130.96M | -796.49M |
Selling & General & Admin | 240.79M | 238.44M | 227.54M | 231.4M | 263.36M | 248.95M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 284.62M | 186.7M | 62.95M | 46.97M | 102.24M |
Operating Expenses | 240.79M | 523.06M | 414.24M | 294.35M | 310.32M | 351.19M |
Interest Expense | 35.97M | 40.74M | 42.08M | 39.7M | 68.72M | 110.48M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.68B | 2.08B | 1.99B | 1.8B | 1.71B | 1.64B |
Income Tax Expense | 51.04M | -2.27M | 12.05M | 18.81M | 27.24M | 16.73M |
Shares Outstanding (Basic) | 85.27M | 83.33M | 84.02M | 82.95M | 86.42M | 85.59M |
Shares Outstanding (Diluted) | 85.27M | 83.33M | 82.2M | 84.12M | 86.42M | 85.59M |
EPS (Basic) | 1.94 | -1.19 | -0.72 | 0.80 | 1.52 | -9.31 |
EPS (Diluted) | 1.94 | -1.19 | -0.73 | 0.79 | 1.52 | -9.55 |
EBITDA | 274.22M | -28.37M | 29.89M | 156.7M | 236.1M | 146.07M |
EBIT | 252.4M | -60.6M | -6.28M | 121.07M | 203.95M | 117.63M |
Depreciation & Amortization | 21.83M | 32.23M | 36.17M | 35.64M | 32.15M | 28.44M |
Add to Watchlist
Select watchlists to add or remove MD